123 related articles for article (PubMed ID: 34230998)
21. Incidence, surgical procedures, and outcomes of hip fracture among elderly type 2 diabetic and non-diabetic patients in Spain (2004-2013).
Lopez-de-Andrés A; Jiménez-García R; Jiménez-Trujillo I; Hernández-Barrera V; de Miguel-Yanes JM; Méndez-Bailón M; Perez-Farinos N; de Miguel-Diez J; Salinero-Fort MÁ; Carrasco-Garrido P
Osteoporos Int; 2016 Feb; 27(2):605-16. PubMed ID: 26318760
[TBL] [Abstract][Full Text] [Related]
22. Diabetes mellitus and risk of hip fractures: a meta-analysis.
Fan Y; Wei F; Lang Y; Liu Y
Osteoporos Int; 2016 Jan; 27(1):219-28. PubMed ID: 26264604
[TBL] [Abstract][Full Text] [Related]
23. Association of lower urinary tract symptoms and hip fracture in adults aged ≥ 50 years.
Liu PS; Huang HK; Ding DC
PLoS One; 2021; 16(3):e0246653. PubMed ID: 33657118
[TBL] [Abstract][Full Text] [Related]
24. Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study.
Chan CW; Yu CL; Lin JC; Hsieh YC; Lin CC; Hung CY; Li CH; Liao YC; Lo CP; Huang JL; Lin CH; Wu TJ
Cardiovasc Diabetol; 2018 Jan; 17(1):20. PubMed ID: 29368615
[TBL] [Abstract][Full Text] [Related]
25. Progression to insulin for patients with diabetes mellitus using the Texas Medicaid database.
Rascati KL; Richards KM; Lopez D; Cheng LI; Wilson JP
Clin Ther; 2011 Dec; 33(12):2016-20. PubMed ID: 22101160
[TBL] [Abstract][Full Text] [Related]
26. Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study.
Lu CJ; Sun Y; Muo CH; Chen RC; Chen PC; Hsu CY
Cerebrovasc Dis; 2013; 36(2):145-51. PubMed ID: 24029780
[TBL] [Abstract][Full Text] [Related]
27. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.
Tseng CH
Oncotarget; 2017 Jan; 8(2):3042-3048. PubMed ID: 27936468
[TBL] [Abstract][Full Text] [Related]
28. Thiazolidinediones and fractures: evidence from translating research into action for diabetes.
Bilik D; McEwen LN; Brown MB; Pomeroy NE; Kim C; Asao K; Crosson JC; Duru OK; Ferrara A; Hsiao VC; Karter AJ; Lee PG; Marrero DG; Selby JV; Subramanian U; Herman WH
J Clin Endocrinol Metab; 2010 Oct; 95(10):4560-5. PubMed ID: 20631021
[TBL] [Abstract][Full Text] [Related]
29. Association between Smoking Status and the Risk of Hip Fracture in Patients with Type 2 Diabetes: A Nationwide Population-Based Study.
Lee SW; Heu JY; Kim JY; Kim J; Han K; Kwon HS
Endocrinol Metab (Seoul); 2023 Dec; 38(6):679-689. PubMed ID: 38053226
[TBL] [Abstract][Full Text] [Related]
30. Influence of Premature Mortality on the Link Between Type 2 Diabetes and Hip Fracture: The Fremantle Diabetes Study.
Hamilton E; Davis WA; Bruce DG; Davis TM
J Clin Endocrinol Metab; 2017 Feb; 102(2):551-559. PubMed ID: 27880070
[TBL] [Abstract][Full Text] [Related]
31. Type 2 Diabetes and Risk of Hip Fractures and Non-Skeletal Fall Injuries in the Elderly: A Study From the Fractures and Fall Injuries in the Elderly Cohort (FRAILCO).
Wallander M; Axelsson KF; Nilsson AG; Lundh D; Lorentzon M
J Bone Miner Res; 2017 Mar; 32(3):449-460. PubMed ID: 27664946
[TBL] [Abstract][Full Text] [Related]
32. Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study.
Lin HC; Hsu YT; Kachingwe BH; Hsu CY; Uang YS; Wang LH
J Clin Pharm Ther; 2014 Aug; 39(4):354-60. PubMed ID: 24661226
[TBL] [Abstract][Full Text] [Related]
33. Comparative cost-effectiveness of metformin-based dual therapies associated with risk of cardiovascular diseases among Chinese patients with type 2 diabetes: Evidence from a population-based national cohort in Taiwan.
Ou HT; Chen YT; Liu YM; Wu JS
Diabetes Res Clin Pract; 2016 Jun; 116():14-25. PubMed ID: 27321311
[TBL] [Abstract][Full Text] [Related]
34. [Diabetes mellitus and risk of hip fracture. A systematic review].
Formiga F; Freitez Ferreira MD; Montero A
Rev Esp Geriatr Gerontol; 2020; 55(1):34-41. PubMed ID: 31668564
[TBL] [Abstract][Full Text] [Related]
35. Use of glucose-lowering drugs and risk of fracture in patients with type 2 diabetes.
Starup-Linde J; Gregersen S; Frost M; Vestergaard P
Bone; 2017 Feb; 95():136-142. PubMed ID: 27890548
[TBL] [Abstract][Full Text] [Related]
36. Effect of benign prostatic hyperplasia on the development of spine, hip, and wrist fractures.
Yang SC; Chiu YC; Liu PH; Hsieh TJ; Kao YH; Tu YK
Osteoporos Int; 2019 May; 30(5):1043-1049. PubMed ID: 30706096
[TBL] [Abstract][Full Text] [Related]
37. Contemporary risk of hip fracture in type 1 and type 2 diabetes: a national registry study from Scotland.
Hothersall EJ; Livingstone SJ; Looker HC; Ahmed SF; Cleland S; Leese GP; Lindsay RS; McKnight J; Pearson D; Philip S; Wild SH; Colhoun HM
J Bone Miner Res; 2014; 29(5):1054-60. PubMed ID: 24155126
[TBL] [Abstract][Full Text] [Related]
38. Pioglitazone and oral cancer risk in patients with type 2 diabetes.
Tseng CH
Oral Oncol; 2014 Feb; 50(2):98-103. PubMed ID: 24239280
[TBL] [Abstract][Full Text] [Related]
39. Diabetes mellitus and the risk of non-vertebral fractures: the Tromsø study.
Ahmed LA; Joakimsen RM; Berntsen GK; Fønnebø V; Schirmer H
Osteoporos Int; 2006; 17(4):495-500. PubMed ID: 16283065
[TBL] [Abstract][Full Text] [Related]
40. Thiazolidinediones and fractures in men and women.
Dormuth CR; Carney G; Carleton B; Bassett K; Wright JM
Arch Intern Med; 2009 Aug; 169(15):1395-402. PubMed ID: 19667303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
